Literature DB >> 21190185

Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease.

Sokratis Trellakis1, Kirsten Bruderek, Claudia A Dumitru, Hossein Gholaman, Xiang Gu, Agnes Bankfalvi, André Scherag, Jan Hütte, Nina Dominas, Götz F Lehnerdt, Thomas K Hoffmann, Stephan Lang, Sven Brandau.   

Abstract

The progression of epithelial cancer is associated with an intense immunological interaction between the tumor cells and immune cells of the host. However, little is known about the interaction between tumor cells and polymorphonuclear granulocytes (PMNs) in patients with head and neck squamous cell carcinoma (HNSCC). In our study, we investigated systemic PMN-related alterations in HNSCC, the role of tumor-infiltrating PMNs and their modulation by the tumor microenvironment. We assessed the infiltration of HNSCC tissue by PMNs (retrospectively) and systemic PMN-related alterations in blood values (prospectively) in HNSCC patients (n = 99 and 114, respectively) and control subjects (n = 41). PMN recruitment, apoptosis and inflammatory activity were investigated in an in vitro system of peripheral blood PMNs and a human HNSCC cell line (FaDu). HNSCC tissue exhibited considerable infiltration by PMNs, and strong infiltration was associated with poorer survival in advanced disease. PMN count, neutrophil-to-lymphocyte ratio and serum concentrations of CXCL8 (interleukin-8), CCL4 (MIP-1β) and CCL5 (RANTES) were significantly higher in the peripheral blood of HNSCC patients than in that of controls. In vitro, HNSCC-conditioned medium inhibited apoptosis of PMNs, increased chemokinesis and chemotaxis of PMNs, induced release of lactoferrin and matrix metalloproteinase 9 by PMNs and enhanced the secretion of CCL4 by PMN. Our findings demonstrate alterations in PMN biology in HNSCC patients. In vitro, tumor-derived factors modulate cellular functions of PMNs and increase their inflammatory activity. Thus, the interaction between HNSCC and PMNs may contribute to host-mediated changes in the tumor microenvironment.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21190185     DOI: 10.1002/ijc.25892

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  101 in total

Review 1.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

2.  Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils.

Authors:  Haibin Lu; Baolei Wu; Ge Ma; Deyu Zheng; Ruijuan Song; Erjiang Huang; Ming Mao; Bin Lu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma.

Authors:  Saleh Rachidi; Kristin Wallace; John M Wrangle; Terry A Day; Anthony J Alberg; Zihai Li
Journal:  Head Neck       Date:  2015-09-28       Impact factor: 3.147

Review 4.  Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.

Authors:  Evgeniy B Eruslanov; Sunil Singhal; Steven M Albelda
Journal:  Trends Cancer       Date:  2017-01-19

Review 5.  Protumor and antitumor functions of neutrophil granulocytes.

Authors:  Sven Brandau; Claudia A Dumitru; Stephan Lang
Journal:  Semin Immunopathol       Date:  2012-09-25       Impact factor: 9.623

6.  High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer.

Authors:  Christos Perisanidis; Gabriela Kornek; Paul W Pöschl; Daniel Holzinger; Katharina Pirklbauer; Christian Schopper; Rolf Ewers
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

Review 7.  Neutrophils in innate and adaptive immunity.

Authors:  Sébastien Jaillon; Maria Rosaria Galdiero; Davide Del Prete; Marco Antonio Cassatella; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

8.  Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic Factor.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Hideki Ujiie; Daniel H Buitrago; Kaitlin M Woo; Camelia S Sima; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

9.  Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

Authors:  Chunxiao Xu; Christine M Fillmore; Shohei Koyama; Hongbo Wu; Yanqiu Zhao; Zhao Chen; Grit S Herter-Sprie; Esra A Akbay; Jeremy H Tchaicha; Abigail Altabef; Jacob B Reibel; Zandra Walton; Hongbin Ji; Hideo Watanabe; Pasi A Jänne; Diego H Castrillon; Anil K Rustgi; Adam J Bass; Gordon J Freeman; Robert F Padera; Glenn Dranoff; Peter S Hammerman; Carla F Kim; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2014-05-01       Impact factor: 31.743

10.  Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.

Authors:  Steve Oghumu; Thomas J Knobloch; Cesar Terrazas; Sanjay Varikuti; Jennifer Ahn-Jarvis; Claire E Bollinger; Hans Iwenofu; Christopher M Weghorst; Abhay R Satoskar
Journal:  Int J Cancer       Date:  2016-06-16       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.